REGEN BIOPHARMA, INC. Cash and Restricted Cash
REGEN BIOPHARMA, INC. (RGBP) had Cash and Restricted Cash of $61.85 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-08-13
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.85K.
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.11K.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $124.50K.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $121.04K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-06-30 | $61.85K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $78.11K 10-Q · filed 2024-04-24 |
| 2023-12-31 | $124.50K 10-Q · filed 2024-01-19 |
| 2023-09-30 | $121.04K 10-Q · filed 2024-08-13 |
| 2023-06-30 | $692.00 10-Q · filed 2024-08-13 |
| 2023-03-31 | $87.70K 10-Q · filed 2024-04-24 |
| 2022-12-31 | $40.74K 10-Q · filed 2024-01-19 |
| 2022-09-30 | $51.20K 10-Q · filed 2024-08-13 |
| 2022-06-30 | $110.99K 10-Q · filed 2023-07-25 |
| 2022-03-31 | $234.67K 10-Q · filed 2023-04-18 |
| 2021-12-31 | $353.49K 10-Q · filed 2023-01-19 |
| 2021-09-30 | $727.16K 10-K · filed 2023-11-20 |
| 2021-06-30 | $188.18K 10-Q · filed 2022-07-22 |
| 2020-09-30 | $0.00 10-Q · filed 2022-07-22 |